1. Genetic test for risk from Camptosar licensed

   Media release 21 January 2013 Pages: 2 - 2

2. Rosiglitazone associated with reports of retinal oedema

   News item 21 January 2013 Pages: 2 - 2

3. Safety updates to US labelling for WinRho SDF

   Correspondence 21 January 2013 Pages: 2 - 2

4. Health Canada warns consumers against ingesting chaparral

   Media release 21 January 2013 Pages: 3 - 3

5. Kaizen Ephedrine HCL misuse potentially fatal

   Media release 21 January 2013 Pages: 3 - 3

6. MHRA removes M2 and Energy 2000 from UK market

   Media release 21 January 2013 Pages: 3 - 3

7. Pfizer sponsoring new Celebrex study

   News item 21 January 2013 Pages: 3 - 3

8. Precautions for fludarabine use revised in Japan

   News item 21 January 2013 Pages: 3 - 3

9. Swedish study shows heart defect risk with paroxetine

   News item 21 January 2013 Pages: 3 - 3

10. ACP-103 shows promise in haloperidol-induced akathisia

    Media release 21 January 2013 Pages: 4 - 4

11. Anti-TNF antibodies linked to malignancies and serious infections

    Incidence study 21 January 2013 Pages: 4 - 4

12. Does baseline CD4+ count for ART AEs?

    Clinical study 21 January 2013 Pages: 4 - 4

13. Fluoroquinolone use a risk factor for CDAD

    Non-clinical study 21 January 2013 Pages: 4 - 4

14. Fluvoxamine causes caffeine concentration climb

    Volunteers 21 January 2013 Pages: 5 - 5

15. Gastric acid suppressants increase community-acquired C. difficile risk

    Clinical study 21 January 2013 Pages: 5 - 5

16. HRT use may not increase breast cancer incidence in Japan

    Incidence study 21 January 2013 Pages: 5 - 5

17. Ondansetron scratches morphine-induced pruritus

    News item 21 January 2013 Pages: 5 - 5

18. Aciclovir

    Case report 21 January 2013 Pages: 6 - 6

19. Alosetron

    Case report 21 January 2013 Pages: 6 - 6

20. Alprazolam/dipotassium clorazepate/sertraline

    Case report 21 January 2013 Pages: 6 - 6

21. Alteplase

    Case report 21 January 2013 Pages: 7 - 7

22. Amprenavir/didanosine/stavudine

    Case report 21 January 2013 Pages: 7 - 7

23. Anaesthetics

    Case report 21 January 2013 Pages: 7 - 7

24. Antiretrovirals

    Case report 21 January 2013 Pages: 7 - 8

25. Antiretrovirals withdrawal

    Case report 21 January 2013 Pages: 8 - 8

26. Aripiprazole

    Case report 21 January 2013 Pages: 8 - 8

27. Aspirin

    Case report 21 January 2013 Pages: 8 - 8

28. Azathioprine/infliximab

    Case report 21 January 2013 Pages: 8 - 8

29. BCG

    Case report 21 January 2013 Pages: 8 - 9

30. Bimatoprost

    Case report 21 January 2013 Pages: 9 - 9

31. Cefepime

    Case report 21 January 2013 Pages: 9 - 10

32. Cisplatin

    Case report 21 January 2013 Pages: 10 - 10

33. Eptacog-alfa

    Case report 21 January 2013 Pages: 10 - 10

34. Fluorodopa-F-18

    Case report 21 January 2013 Pages: 10 - 10

35. Gefitinib

    Case report 21 January 2013 Pages: 11 - 11

36. Gemcitabine

    Case report 21 January 2013 Pages: 11 - 11

37. Glatiramer acetate

    Case report 21 January 2013 Pages: 11 - 12

38. Glibenclamide

    Case report 21 January 2013 Pages: 12 - 12

39. Halothane/isoflurane/suxamethonium chloride

    Case report 21 January 2013 Pages: 12 - 12

40. Heparin

    Case report 21 January 2013 Pages: 12 - 12

41. Herbal medicines

    Case report 21 January 2013 Pages: 12 - 13

42. Herbal medicines interaction

    Case report 21 January 2013 Pages: 13 - 13

43. Hydrochlorothiazide

    Case report 21 January 2013 Pages: 13 - 14

44. Imipenem/cilastatin

    Case report 21 January 2013 Pages: 14 - 14

45. Influenza virus vaccine

    Case report 21 January 2013 Pages: 14 - 14

46. Interferon-α

    Case report 21 January 2013 Pages: 14 - 14

47. Interferon-α-2a

    Case report 21 January 2013 Pages: 15 - 15

48. Interferon-α-2b

    Case report 21 January 2013 Pages: 15 - 15

49. Interferon-α/interferon-α-2a

    Case report 21 January 2013 Pages: 15 - 16

50. Levocetirizine

    Case report 21 January 2013 Pages: 16 - 16